Ignite Creation Date:
2024-05-06 @ 5:47 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05439369
Status:
UNKNOWN
Last Update Posted:
2022-06-30
First Post:
2022-06-17
Brief Title:
Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease
Status:
UNKNOWN
Status Verified Date:
2022-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
NPs can be used To detect subset of asymptomatic with subtle LV dysfunction for further evaluation and earlier referral for intervention and its correlation with echocardiographic finding
Detailed Description:
Each patient included in the study will undergo
1 History taking
Analysis of patient symptoms and signs dyspnea orthopnea Paroxysmal nocturnal dyspnea lower limb edema tachypalpitationsetc
2 Clinical examination
Detecion of each patient body weight height calculation of BMI
General examination for detection of signs of Heart failure raised JVP lower limb edema etc
Examination to respiratory system
Auscultation of the heart for detection of valvular affection before echocardiography
Invesigations
Laboratory investigations
Urea and creatinine b ECG for exclusion of atrial fibrillation and other arrythmias 2D Transthorathic Echocardiography TTE Evaluation of valve morphology and thickness gradients and valve area regurgitant lesions and its severity
Evaluation of internal cardiac dimensions and function 5- Natriuretic peptides as a useful screening tool to differentiate symptomatic and asymptomatic patients
1 History taking
Analysis of patient symptoms and signs dyspnea orthopnea Paroxysmal nocturnal dyspnea lower limb edema tachypalpitationsetc
2 Clinical examination
Detecion of each patient body weight height calculation of BMI
General examination for detection of signs of Heart failure raised JVP lower limb edema etc
Examination to respiratory system
Auscultation of the heart for detection of valvular affection before echocardiography
Invesigations
Laboratory investigations
Urea and creatinine b ECG for exclusion of atrial fibrillation and other arrythmias 2D Transthorathic Echocardiography TTE Evaluation of valve morphology and thickness gradients and valve area regurgitant lesions and its severity
Evaluation of internal cardiac dimensions and function 5- Natriuretic peptides as a useful screening tool to differentiate symptomatic and asymptomatic patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None